uniQure (QURE) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release

Core Viewpoint - uniQure (QURE) is anticipated to report a year-over-year increase in earnings driven by higher revenues in its upcoming quarterly results for September 2025 [1] Financial Expectations - The consensus estimate indicates a quarterly loss of $0.85 per share, reflecting a year-over-year change of +6.6% [3] - Expected revenues are projected at $6.93 million, representing a significant increase of 202.6% from the same quarter last year [3] Estimate Revisions - The consensus EPS estimate has been revised 4.79% higher in the last 30 days, indicating a positive reassessment by analysts [4] - The Most Accurate Estimate for uniQure is higher than the Zacks Consensus Estimate, resulting in an Earnings ESP of +22.54% [12] Earnings Surprise Potential - A positive Earnings ESP reading suggests a strong likelihood of an earnings beat, especially when combined with a Zacks Rank of 3 [10][12] - Historically, uniQure has beaten consensus EPS estimates three out of the last four quarters, with a notable surprise of +22.47% in the last reported quarter [13][14] Industry Context - In comparison, Axsome Therapeutics (AXSM) is expected to report a loss of $0.85 per share for the same quarter, with revenues projected at $164.05 million, up 56.6% year-over-year [18][19] - Axsome's consensus EPS estimate has been revised 38.2% lower recently, resulting in a negative Earnings ESP of -14.93% [19][20]